New York State Psychiactic Institute
New York, 10032, United States
NCT Number: NCT02378896
This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
New York, 10032, United States
This study will evaluate the effectiveness of a computerized training program (called Personalized Computerized Inhibitory Training, or PCIT) coupled with cognitive behavioral therapies (CBT) consisting of Exposures and Response Prevention in treating obsessive compulsive disorder (OCD) in patients who previously underwent CBT, but still have residual symptoms.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Training with a personalized computerized inhibitory training program
Cognitive Behavioral Therapy (CBT), consisting of Exposure and Ritual Prevention Therapy
Time frame: 3 weeks
measured by Yale Brown Obsessive Compulsive Scale (YBOCS)
Looking for future studies?
Notify MeNew York State Psychiatric Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06299319
Anxiety Disorders, Mental Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT05624528
Anxiety Disorders, Mental Disorders
Chicago, Illinois, United States
View Trial DetailsNCT03304600
Anxiety Disorders, Mental Disorders
Lyon, France
View Trial DetailsNCT05521074
Anxiety Disorders, Mental Disorders
Boston, Massachusetts, United States
View Trial Details